Continuous 24-h monitoring of electrocardiogram during anthracycline-based therapy in acute leukemia.
Jakl
M
M
Horacek
J M
JM
Jebavy
L
L
Pudil
R
R
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage* / Q000009:adverse effects*; D054715:Cardiotoxins / Q000008:administration & dosage*; D003561:Cytarabine / Q000008:administration & dosage / Q000009:adverse effects; D003630:Daunorubicin / Q000008:administration & dosage / Q000009:adverse effects; D004562:Electrocardiography; D005260:Female; D006331:Heart Diseases / Q000139:chemically induced / Q000503:physiopathology*; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy / Q000503:physiopathology*; D008297:Male; D008875:Middle Aged; D008942:Mitoxantrone / Q000008:administration & dosage / Q000009:adverse effects; D008991:Monitoring, Physiologic / Q000379:methods*
D054715:Cardiotoxins; D003561:Cytarabine; D008942:Mitoxantrone; D003630:Daunorubicin